Merck & Co Analyst Price Targets

PRO

¿Por qué se mueve?:Merck shares are trading higher after reporting better-than-expected Q3 fin...

Ganancias: Los beneficios de Q3 2026 se publicaron el jue oct 29th, antes de la apertura del mercado

Conferencia telefónica: La conferencia telefónica más reciente comenzó a las 9:00 a. m., hace 1 día

Wall Street analyst price targets and consensus rating for Merck & Co (MRK).

Price Target Range — 10 Quarters

Analyst Consensus — 24 Analysts

15Buy

9Hold

Consensus RatingBuy# Analysts24Avg. Consensus PT$146Upside to Avg. PT-3.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 30, 2026	RBC Capital	Trung Huynh	PT Cut	Sector Perform	$145→$140
Oct 30, 2026	Guggenheim	Vamil Divan	PT Raise	Buy	$170→$171
Oct 26, 2026	Barclays	Emily Field	PT Raise	Overweight	$150→$180
Oct 12, 2026	Citigroup	Geoff Meacham	PT Raise	Neutral	$125→$145
Oct 12, 2026	RBC Capital	Trung Huynh	PT Cut	Sector Perform	$150→$145
Oct 8, 2026	Cantor Fitzgerald	Carter Gould	PT Raise	Neutral	$120→$145
Oct 7, 2026	Morgan Stanley	Terence Flynn	PT Cut	Overweight	$179→$177
Oct 5, 2026	JP Morgan	Chris Schott	PT Raise	Overweight	$150→$165
Sep 29, 2026	Scotiabank	Louise Chen	PT Raise	Sector Outperform	$155→$180
Sep 10, 2026	HSBC	Rajesh Kumar	PT Raise	Buy	$150→$172
Sep 9, 2026	Leerink Partners	Daina Graybosch	PT Raise	Outperform	$127→$161
Sep 8, 2026	Guggenheim	Vamil Divan	PT Raise	Buy	$146→$170
Sep 4, 2026	Wells Fargo	Mohit Bansal	PT Raise	Overweight	$150→$170
Aug 25, 2026	Wolfe Research	Alexandria Hammond	PT Raise	Outperform	$155→$180
Aug 25, 2026	Argus Research	Jasper Hellweg	PT Raise	Buy	$145→$170
Aug 21, 2026	Goldman Sachs	Terence Flynn	PT Raise	Buy	$140→$160
Aug 20, 2026	BMO Capital	Evan David Seigerman	PT Raise	Outperform	$142→$170
Aug 20, 2026	UBS	Michael Yee	PT Raise	Buy	$145→$175
Aug 20, 2026	RBC Capital	Trung Huynh	Downgrade	Outperform→Sector Perform	$142→$150
Aug 20, 2026	Morgan Stanley	Terence Flynn	Upgrade	Equal-Weight→Overweight	$116→$179